These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29052915)

  • 21. Asthma control and quality of life in a real-life setting: a cross-sectional study of adult asthma patients in Japan (ACQUIRE-2).
    Adachi M; Hozawa S; Nishikawa M; Yoshida A; Jinnai T; Tamura G
    J Asthma; 2019 Sep; 56(9):1016-1025. PubMed ID: 30252543
    [No Abstract]   [Full Text] [Related]  

  • 22. Determination of asthma control using administrative data regarding short-acting beta-agonist inhaler purchase.
    Shlomi D; Katz I; Segel MJ; Oberman B; Peled N
    J Asthma; 2018 May; 55(5):571-577. PubMed ID: 28759272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asthma control in severe asthmatics under treatment with omalizumab: a cross-sectional observational study in Italy.
    Novelli F; Latorre M; Vergura L; Caiaffa MF; Camiciottoli G; Guarnieri G; Matucci A; Macchia L; Vianello A; Vultaggio A; Celi A; Cazzola M; Paggiaro P;
    Pulm Pharmacol Ther; 2015 Apr; 31():123-9. PubMed ID: 25281265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of modifiable factors limiting treatment efficacy of poorly controlled asthma patients: EFIMERA observational study.
    Ribó P; Molina J; Calle M; Maiz L; Campo C; Rytilä P; Plaza V; Valero A
    NPJ Prim Care Respir Med; 2020 Jul; 30(1):33. PubMed ID: 32737324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Level of asthma control and health care utilization in Asia-Pacific countries.
    Gold LS; Thompson P; Salvi S; Faruqi RA; Sullivan SD
    Respir Med; 2014 Feb; 108(2):271-7. PubMed ID: 24406243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe asthma in childhood: diagnostic and management challenges.
    Bozzetto S; Carraro S; Zanconato S; Baraldi E
    Curr Opin Pulm Med; 2015 Jan; 21(1):16-21. PubMed ID: 25415405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioral influences on prescription inhaler acquisition for persistent asthma in a patient-centered medical home.
    Lee SJ; Pincus KJ; Williams AA
    Res Social Adm Pharm; 2016; 12(5):789-93. PubMed ID: 26701812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Asthma Control Test (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional survey.
    Thomas M; Kay S; Pike J; Williams A; Rosenzweig JR; Hillyer EV; Price D
    Prim Care Respir J; 2009 Mar; 18(1):41-9. PubMed ID: 19240948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study).
    Munoz-Cano R; Torrego A; Bartra J; Sanchez-Lopez J; Palomino R; Picado C; Valero A
    Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28254764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Factors influencing asthma course and the degree of control in the patients assessed with own questionnaire and Asthma Control Test (ACT)].
    Krasnodębska P; Hermanowicz-Salamon J; Domagała-Kulawik J; Chazan R
    Pneumonol Alergol Pol; 2012; 80(3):198-208. PubMed ID: 22562271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive Properties of the Asthma Control Test and Its Component Questions for Severe Asthma Exacerbations.
    Cajigal S; Wells KE; Peterson EL; Ahmedani BK; Yang JJ; Kumar R; Burchard EG; Williams LK
    J Allergy Clin Immunol Pract; 2017; 5(1):121-127.e2. PubMed ID: 27544712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are the asthma guideline goals achieved in daily practice? A population-based study on treatment adequacy and the control of asthma.
    de Marco R; Cazzoletti L; Cerveri I; Corsico A; Bugiani M; Accordini S; Carrozzi L; Dallari R; De Togni A; Marinoni A; Pirina P; Janson C;
    Int Arch Allergy Immunol; 2005 Nov; 138(3):225-34. PubMed ID: 16210861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Asthma control status in Tunisia].
    Aissa I; Gharsalli H; Khattab A; Driss L; Ghedira H
    Tunis Med; 2010 Feb; 88(2):97-101. PubMed ID: 20415167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants and impact of suboptimal asthma control in Europe: The INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study.
    Braido F; Brusselle G; Guastalla D; Ingrassia E; Nicolini G; Price D; Roche N; Soriano JB; Worth H;
    Respir Res; 2016 May; 17(1):51. PubMed ID: 27179604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of asthma control and patient's perception of asthma: findings and analysis of a nationwide questionnaire-based survey in China.
    Su N; Lin J; Chen P; Li J; Wu C; Yin K; Liu C; Chen Y; Zhou X; Yuan Y; Huang X
    J Asthma; 2013 Oct; 50(8):861-70. PubMed ID: 23713625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adherence rate to beclomethasone dipropionate and the level of asthma control.
    Jentzsch NS; Camargos P; Sarinho ES; Bousquet J
    Respir Med; 2012 Mar; 106(3):338-43. PubMed ID: 22188844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asthma inhaler adherence determinants in adults: systematic review of observational data.
    Dima AL; Hernandez G; Cunillera O; Ferrer M; de Bruin M;
    Eur Respir J; 2015 Apr; 45(4):994-1018. PubMed ID: 25504997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding medication and use of drug delivery device by asthmatic in Lagos.
    Adeyeye OO; Onadeko BO
    West Afr J Med; 2008 Jul; 27(3):155-9. PubMed ID: 19256320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asthma with allergic rhinitis management in China: a nationwide survey of respiratory specialists at tertiary hospitals.
    Su N; Lin J; Liu G; Yin K; Zhou X; Shen H; Chen P; Chen R; Liu C; Wu C; Zhao J; Lin Y
    Int Forum Allergy Rhinol; 2015 Mar; 5(3):221-32. PubMed ID: 25400200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
    Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K
    Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.